IQPC Cell & Gene Therapy Conference, Oct 29-31
The Conference to address process development, technical adoption and manufacturing challenges
Meet Immatics at this year’s Cell & Gene Therapy Conference and get our latest news about the manufacturing of TCR-based T-cell therapies:
Wednesday, Oct 30 (Day 2), 9.45am – 10.20am
Manufacturing of TCR-based T-cell therapies for solid cancers to enable late stage clinical trials
Speaker: Zoe Coughlin, Associate Director CMC
All information about the IQPC Cell & Gene Therapy Conference can be found here.